Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 11/20 | 0.68 |
| ▸ | KDR | P35968 | 10/20 | 0.68 |
| ▸ | FGFR1 | P11362 | 8/20 | 0.68 |
| ▸ | MET | P08581 | 6/20 | 0.68 |
| ▸ | PRKAA2 | P54646 | 4/20 | 0.68 |
| ▸ | PRKAA1 | Q13131 | 4/20 | 0.68 |
| ▸ | CDK2 | P24941 | 2/20 | 0.68 |
| ▸ | PTK2B | Q14289 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | EGFR | P00533 | 2/20 | 0.68 |
| ▸ | KIT | P10721 | 2/20 | 0.68 |
| ▸ | NEK2 | P51955 | 2/20 | 0.68 |
| ▸ | FLT3 | P36888 | 2/20 | 0.68 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.68 |
| ▸ | PLK4 | O00444 | 1/20 | 0.68 |
| ▸ | RIOK3 | O14730 | 1/20 | 0.68 |
| ▸ | CASK | O14936 | 1/20 | 0.68 |
| ▸ | GAK | O14976 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL142020 | 0.97 | KDR (0.65) | PDGFRBKDRFGFR1METPRKAA2 | |
| SCHEMBL147422 | 0.93 | KDR (0.66) | PDGFRBKDRFGFR1METPRKAA2 | |
| SCHEMBL143796 | 0.91 | FGFR1 (0.63) | PDGFRBKDRFGFR1METPRKAA2 | |
| SCHEMBL141110 | 0.90 | KDR (0.67) | PDGFRBKDRFGFR1METPRKAA2 | |
| SCHEMBL142619 | 0.88 | KDR (0.69) | PDGFRBKDRFGFR1METPRKAA2 | |
| SCHEMBL144210 | 0.88 | KDR (0.62) | PDGFRBKDRFGFR1METPRKAA2 | |
| SCHEMBL146613 | 0.88 | FGFR1 (0.60) | PDGFRBKDRFGFR1METPRKAA2 | |
| SCHEMBL145248 | 0.87 | KDR (0.63) | PDGFRBKDRFGFR1METPRKAA2 | |
| SCHEMBL147096 | 0.87 | KDR (0.69) | PDGFRBKDRFGFR1METPRKAA2 | |
| SCHEMBL145952 | 0.86 | KDR (0.88) | PDGFRBKDRFGFR1METPRKAA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120059047-A1 | DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR | VERVA PHARMACEUTICALS PTY LTD (AU) | 2012-03-08 | — | — | US | disclosed |
| US-20050282733-A1 | Differentiation modulating agents and uses therefor | VERVA PHARMACEUTICALS PTY LTD (AU) | 2005-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059047-A1 | DIFFERENTIATION MODULATING AGENTS AND USES THEREFOR | FGF1, FABP4, FGF2 | PDGFRB 467/4885KDR 1077/4885FGFR1 5/4885 |
| US-20050282733-A1 | Differentiation modulating agents and uses therefor | FGF1, FABP4, FGF2 | PDGFRB 467/4885KDR 1077/4885FGFR1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.